DrugPatentWatch Database Preview
Drugs in Development Information for Bicine
» See Plans and Pricing
What is the development status for investigational drug Bicine?
Bicine is an investigational drug.
There have been 33 clinical trials for Bicine.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Breast Neoplasms, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Gruppo Italiano Malattie EMatologiche dell'Adulto, University of Cologne, and Hellenic Oncology Research Group.
Summary for Bicine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,932 |
| WIPO Patent Applications | 1,995 |
| Japanese Patent Applications | 5 |
| Clinical Trial Progress | Phase 3 (2010-05-01) |
| Vendors | 76 |
Recent Clinical Trials for Bicine
| Title | Sponsor | Phase |
|---|---|---|
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients | Changzhou No.2 People's Hospital | Phase 3 |
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients | Huai'an Second People's Hospital | Phase 3 |
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients | Jingjiang People's Hospital | Phase 3 |
Clinical Trial Summary for Bicine
Top disease conditions for Bicine
Top clinical trial sponsors for Bicine
US Patents for Bicine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
